APICONA THEME FOR MEDICAL AND HEALTH WEBSITES
Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat nulla facilisi.
ADVANCED TECHNOLOGY
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam quis placerat urna. Nulla nulla diam, adipiscing non ornare non, commodo adipiscing elit.
24/7 AVAILABILITY
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam quis placerat urna. Nulla nulla diam, adipiscing non ornare non, commodo adipiscing elit.
HEALTHCARE SOLUTIONS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam quis placerat urna. Nulla nulla diam, adipiscing non ornare non, commodo adipiscing elit.
WHAT OUR PATIENT SAY
Mirum est notare quam littera gothica, quam nunc putamus parum claram
The doctor and his assistant always take such time and care to do the best job possible. It's greatly appreciated.
Both Holly and Dr Cummings have made me feel comfortable. I would recommend DaVinci Med to anyone seeking to remove unsightly and unwanted hair.
Botox Results
Chicago Aesthetics Conference
Hair restoration research with medications
Cosmetic hair restoration is an issue that many men and women suffer with with male pattern baldness and thinning hair. A group of researchers at the University of Manchester published a study showing how the side effects of some medications can actually be used to help stimulate hair growth. A drug that has been around since the 1980’s called Cyclosporine A had a side effect of patients having hair growth. The researchers discovered that the drug has in it an inhibitory mechanism that stops the body from using a certain protein that inhibits the growth of hair cells. The researchers used donated human hair follicles and found they promoted the human hair growth in the laboratory. Further research is needed.
Minimally invasive procedures which promote blood circulation in the scalp and stimulate growth factors include micro-needling with or without platelet rich plasma PRP.
- Nathan J. Hawkshaw, Jonathan A. Hardman, Iain S. Haslam, Asim Shahmalak, Amos Gilhar, Xinhong Lim, Ralf Paus. Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles. PLOS Biology, 2018; 16 (5): e2003705 DOI: 10.1371/journal.pbio.2003705
Rotator Cuff Tears and Stem Cells
Regenerative medicine with stem cells for rotator cuff injuries is being researched. Rotator cuff injuries are a common problem with the shoulder. The rotator cuff is a set of muscles and tendons which provide stability for the shoulder and allows extensive movement. The rotator cuff is prone to injury either through something abruptly happening or wear and tear or a combination of both. Often these injuries are difficult to heal and sometimes require surgery. In regenerative medicine, the body's own healing potentials are attempted to be harnessed. Stem cells can grow into different types of cells. Researchers at the University of Michigan analyzed the stem cells that surround the rotator cuff and found that there were markers present that were more likely to produce new fat growth instead of new muscle growth when compared to other stem cells around other muscles in the body. This sheds light on to the possibility of taking stem cells from a different part of the body and placing them near the rotator cuff to help develop stronger muscle and tendon.
https://insights.ovid.com/crossref?an=00004623-201902060-00004
Identifying higher risk prostate cancer patients
A study that was published in the January issue of Mayo Clinic proceedings indicated genetic alterations maybe used as a marker in determining higher risk prostate cancer patients. When a man is diagnosed with prostate cancer and it is felt to be lower risk, treatment decisions have to be made between them and their doctor. The publication indicated that genetic markers may be analyzed in these patients to help determine if they should be more aggressive with their treatment or not. This is good news for men's health and working with their physician.
https://www.mayoclinicproceedings.org/article/S0025-6196(18)30546-9/fulltext
Elevated levels of a newly discovered molecule responsible for aging bones
Researchers at the Medical College of Georgia at Augusta University have uncovered exciting evidence of systemic alterations that occur with age. Their work has revealed how bones weaken and deteriorate in the aging body. One molecule in particular - microRNA-141-3P - appears to accumulate in bone tissue over time. Scientists have found that elevated levels of microRNA-141-3P are associated with osteoporosis and assorted bone pathology. The problematic molecule inhibits the absorption of vitamin C by various bone cells. It prevents the skeleton from effectively utilizing vitamin C - slowly starving bones of a much needed nutrient. This systemic shift in nutrition limits the resources available for normal bone growth. Over time, aging bones weaken and osteoporosis can develop. Researchers suspected that suppressing microRNA-141-3P could keep bones processing vitamin C and regenerating themselves for far longer than they would under normal aging conditions. Rodent test subjects were treated with a clinical grade inhibitor of microRNA-141-3P; the result was younger, stronger bones. Scientists theorize that a similar inhibiting medication could be used in human subjects to reverse and prevent bone deterioration. The research is compelling and paints an optimistic picture of beneficial anti-aging therapy. Development and distribution of this drug are likely far in the future. Nevertheless, the research indicates that scientists may be able to keep bones younger, for longer. By regulating a single key component of a complex cellular network, bone aging may be prevented.- Sudharsan Periyasamy-Thandavan, John Burke, Bharati Mendhe, Galina Kondrikova, Ravindra Kolhe, Monte Hunter, Carlos M Isales, Mark W Hamrick, William D Hill, Sadanand Fulzele. MicroRNA-141-3p negatively modulates SDF-1 expression in age dependent pathophysiology of human and murine bone marrow stromal cells. The Journals of Gerontology: Series A, 2018; DOI: 10.1093/gerona/gly186